Sumatriptan (Migratan (100 mg)) is a selective serotonin receptor agonist, prescribed for the acute treatment of migraine attacks with or without aura in adults (severe, throbbing headaches that ...
YARDLEY, Pa., Oct. 2, 2012 /PRNewswire/ -- OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE:RDY) today announced that it has launched the authorized generic version of GlaxoSmithKline's Imitrex® (sumatriptan succinate) tablets ...
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine --Migraine Sufferers ...
MUMBAI, Feb 1 (Reuters) - Drug maker Aurobindo Pharma Ltd said on Friday it received tentative approval from the U.S. Food and Drug Administration for its sumatriptan succinate tablets, used to treat ...
1 Pediatric Headache Fellow, Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA. 2 ...
NORTH WALES, Pa. Teva Pharmaceuticals on Monday announced the availability of sumatriptan succinate tablets, which is bioequivalent to GlaxoSmithKline’s Imitrex tablets and indicated for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results